
人工智能如何推动生命科学领域从“重磅药物”转向持续研发
数十年来,生命科学创新一直遵循着一种熟悉的模式:识别有前景的分子,通过线性研发管道推进,最终将其推向市场。从降低心血管疾病死亡率的他汀类药物,到治愈丙型肝炎的疗法,这一模式带来了许多令人瞩目的重磅药物突破。
Chia Tai Tianqing
Expertise
Digital Transformation Strategy Planning: At Chia Tai Tianqing, I am responsible for driving the company's digital transformation. I can develop comprehensive and forward-looking digital transformation strategies that align with the characteristics of the pharmaceutical industry and the company's development needs. By introducing advanced information technologies, I optimize the company's R&D, production, sales, and management processes, enhancing operational efficiency and competitiveness.
Data-Driven Decision Support: I excel at building data management systems, integrating various data resources within the company, and using data analysis tools and technologies to support strategic decision-making. Through data mining and analysis, I identify potential business opportunities and risks, enabling the company to make precise decisions.
System Integration and Information Construction: With extensive experience in system integration, I can coordinate the needs of different departments and promote the integration and optimization of information systems such as ERP, CRM, and MES. By leveraging information technology, I break down information silos between departments, achieve data interconnectivity, and improve the company's overall collaborative efficiency.
Areas of Interest
Application of Artificial Intelligence in Pharmaceutical R&D: I am highly interested in the application of artificial intelligence technology in drug research and development. I actively explore how to use machine learning algorithms for drug target prediction, drug screening, and drug design to improve R&D efficiency and success rates.
Big Data and Precision Medicine: I pay attention to the application of big data technology in precision medicine. I hope to analyze patients' genetic data, clinical data, and lifestyle data to provide personalized treatment plans and enhance therapeutic outcomes.
Digital Healthcare Ecosystem Construction: I am committed to promoting the construction of a digital healthcare ecosystem. This includes collaborating with medical institutions, research organizations, and government departments to explore innovative applications of digital technology in the healthcare field and improve the quality and accessibility of medical services.
数十年来,生命科学创新一直遵循着一种熟悉的模式:识别有前景的分子,通过线性研发管道推进,最终将其推向市场。从降低心血管疾病死亡率的他汀类药物,到治愈丙型肝炎的疗法,这一模式带来了许多令人瞩目的重磅药物突破。
For decades, life sciences innovation has followed a familiar model: Identify a promising molecule, advance it through a linear pipeline and bring it to market. This approach has delivere...
